Optimization of 4-Substituted Benzenesulfonamide Scaffold To Reverse Acinetobacter baumannii Serum-Adaptive Efflux Associated Antibiotic Tolerance.

ChemMedChem
Michaelle ChojnackiDaniel P Flaherty

Abstract

Acinetobacter baumannii is a nosocomial pathogen of urgent concern for public health due to rising rates of multidrug and pandrug resistance. In the context of environmental cues such as growth in human serum, A. baumannii is known to display adaptive efflux, in which a multitude of efflux-associated genes are upregulated, resulting in efflux-mediated drug tolerance in strains that are otherwise susceptible to antibiotic therapy. Previously, we identified a sulfonamide-containing scaffold molecule (ABEPI1) that reversed serum-associated antibiotic tolerance in A. baumannii. Herein, we present structure-activity relationship studies on 29 newly synthesized analogues. These molecules were characterized for their ability to potentiate multiple antibiotics in serum, reduce serum-associated ethidium bromide efflux and depolarize bacterial cell membranes. In addition, they were assessed for toxicity to mammalian cells. Collectively, these molecules may represent promising potential adjuvants for use in combination with new and existing antibiotics to treat A. baumannii bacterial infections.

References

Apr 9, 2001·Critical Care Medicine·M S Niederman
Mar 29, 2005·Antimicrobial Agents and Chemotherapy·Ad C FluitDana Milatovic
Sep 29, 2005·Antimicrobial Agents and Chemotherapy·Xian-Zhong SuTomofusa Tsuchiya
Nov 4, 2006·The Journal of Antimicrobial Chemotherapy·Anton Y PelegDavid L Paterson
Mar 14, 2007·The Journal of Antimicrobial Chemotherapy·Shiri Navon-VeneziaYehuda Carmeli
Apr 11, 2007·Antimicrobial Agents and Chemotherapy·Anton Y PelegDavid L Paterson
Nov 17, 2007·Nature Reviews. Microbiology·Lenie DijkshoornHarald Seifert
Dec 19, 2007·Antimicrobial Agents and Chemotherapy·Laurence Damier-PiollePatrice Courvalin
Dec 24, 2009·Antimicrobial Agents and Chemotherapy·M Indriati HoodEric P Skaar
Aug 11, 2010·Antimicrobial Agents and Chemotherapy·Sébastien CoyneBruno Périchon
Jan 4, 2012·FEMS Immunology and Medical Microbiology·Anna C JacobsPaul M Dunman
Oct 5, 2012·Clinical Microbiology Reviews·Lucía Fernández, Robert E W Hancock
Aug 13, 2014·Antimicrobial Agents and Chemotherapy·Catlyn BlanchardPaul M Dunman
Feb 14, 2015·PLoS Pathogens·Edward Geisinger, Ralph R Isberg
Apr 18, 2015·Nucleic Acids Research·David LagorceBruno O Villoutreix
May 6, 2016·Frontiers in Cell and Developmental Biology·J Derk Te WinkelHenrik Strahl
Mar 30, 2017·Frontiers in Cellular and Infection Microbiology·Chang-Ro LeeSang Hee Lee
Dec 19, 2017·Nature Reviews. Microbiology·Christian M HardingMario F Feldman
Jun 7, 2019·PLoS Pathogens·Victor I Band, David S Weiss
Feb 28, 2020·Infection and Drug Resistance·Seyyed Naser AbdiHossein Samadi Kafil

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

© 2021 Meta ULC. All rights reserved